爱康医疗(01789.HK):公司生产的3D打印定制式胸椎完成植入
格隆汇1月13日丨爱康医疗(01789.HK)公布,于2020年1月9日,公司生产的3D打印定制式胸椎,在北京大学第三医院成功于手术中完成植入。该手术是2020年1月1日施行《定制式医疗器械监督管理规定(试行)》后,完成的第一台定制式医疗器械植入手术。
公告称,随着3D打印定制式假体的植入完成,公司又进一步实现了3D打印定制化植入物的商业化。公司有信心未来为中国骨科医生提供更多优质的产品,满足患者的需求,并借此契机,进一步推动中国骨科植入物领域的技术创新。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.